CN Patent

CN111356479A — 含有白桦脂醇的桦树皮提取物及其制剂

Assigned to Anrui Pharmaceutical designated event company · Expires 2020-06-30 · 6y expired

What this patent protects

本公开涉及桦树皮提取物、生产此类提取物的方法、包含此类提取物的稳定药物组合物以及此类提取物的使用方法。本公开的所述桦树皮提取物含有三萜，所述三萜已知改善伤口愈合。

USPTO Abstract

本公开涉及桦树皮提取物、生产此类提取物的方法、包含此类提取物的稳定药物组合物以及此类提取物的使用方法。本公开的所述桦树皮提取物含有三萜，所述三萜已知改善伤口愈合。

Drugs covered by this patent

Patent Metadata

Patent number
CN111356479A
Jurisdiction
CN
Classification
—
Expires
2020-06-30
Drug substance claim
No
Drug product claim
No
Assignee
Anrui Pharmaceutical designated event company
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.